Literature DB >> 8372607

The psychogenic effects of prolactin.

L G Sobrinho1.   

Abstract

Prolactin modulates maternal functions and is involved in behaviour. Binding sites have been identified in the hypothalamus and substantia nigra. Hyperprolactinaemia stimulates dopamine turnover in several areas of the brain, including the nucleus accumbens, and reduces turnover in other regions, e.g. the substantia nigra. Hyperprolactinaemia stimulates the opioidergic system. The portal concentration of dopamine and oxytocin (a prolactin stimulatory substance) may be increased in hyperprolactinaemia. In mammals, prolactin is associated with learning, stimulation of the immune response, reduction of body temperature and increased corticosterone secretion. It is involved in the behavioural aspect of reproduction. Secretion is strongly stimulated in the female rat on exposure to pups. Hyperprolactinaemia in male rats reduces sexual behaviour. Hyperprolactinaemia reduces libido in both men and women but in men it is also associated with low testosterone levels. There is evidence that in families characterized by an absent or alcoholic father young girls may be predisposed to develop hyperprolactinaemia later in life as a reaction to losses. The underlying mechanism of such a psychosomatic reaction, a typical example of which is pseudopregnancy, may be an extemporaneous activation of a neuroendocrine "maternal subroutine" characteristic of pregnancy. Prolactinomas may result from somatic changes occurring in activated lactotrophs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372607

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

Review 1.  Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans.

Authors:  Tillmann H C Krüger; Uwe Hartmann; Manfred Schedlowski
Journal:  World J Urol       Date:  2005-05-12       Impact factor: 4.226

Review 2.  Growth hormone, prolactin, and sexuality.

Authors:  M Galdiero; R Pivonello; L F S Grasso; A Cozzolino; A Colao
Journal:  J Endocrinol Invest       Date:  2012-09       Impact factor: 4.256

Review 3.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia.

Authors:  J A Den Boer; H J van Megen; W W Fleischhacker; J W Louwerens; B R Slaap; H G Westenberg; G D Burrows; O N Srivastava
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.